Prospective Evaluation of Health-Related Quality of Life in Patients with Metastatic Urothelial Carcinoma Undergoing Immunotherapy with Pembrolizumab: Symptom Burden Can Predict Survival

INTRODUCTION: Despite the fact that guidelines recommend monitoring of quality of life during all phases of treatment in urothelial carcinoma, prospective data about health-related quality of life (HRQoL) in metastatic urothelial carcinoma undergoing immunotherapy are sparse. Consequently, we perfor...

Descripción completa

Detalles Bibliográficos
Autores principales: Schneidewind, Laila, Dräger, Desirée Louise, Roßberg, Vanessa, Nolting, Julia, Hakenberg, Oliver W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9909715/
https://www.ncbi.nlm.nih.gov/pubmed/36244329
http://dx.doi.org/10.1159/000526962

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9909715/
https://www.ncbi.nlm.nih.gov/pubmed/36244329
http://dx.doi.org/10.1159/000526962

Ejemplares similares